About This Fund
BioStar Ventures V is a VC fund located in Charlevoix, Michigan (U.S.). The fund invests in the United States, Europe, and Israel. BioStar expects to invest in 8-10 additional companies over the next five years focusing on making impactful and transformational investments in medical technologies including devices, digital health, robotics, and diagnostics with an emphasis on cardiovascular and orthopedics, two of the most dynamic areas of growth in healthcare. BioStar Capital’s Fund V portfolio includes some of today’s most innovative medical device companies: - Amplitude Vascular Systems (AVS), developing a groundbreaking intravascular lithotripsy device for treating heavily calcified arteries; - Medical Microinstruments (MMI), which has successfully commercialized its revolutionary robotic device that represents the only robot that permits doctors to operate at microsurgical levels for precision reconstruction of small blood vessels, nerves and lymphatics using the world’s smallest wristed surgical instruments; - REVA Medical, which has developed the MOTIV Bioresorbable Scaffold that is designed to treat below-the-knee peripheral artery disease and is the first bioresorbable scaffold to obtain CE Mark approval for treating this disease; and - Versa Vascular, currently developing a non-tissue, non-mechanical, catheter-delivered implant for treating tricuspid valve regurgitation.